ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Xinmaikang-mediated mitophagy attenuates atherosclerosis via the PINK1/Parkin signaling pathway

Cao, Yanhong; Chen, Xin; Pan, Fuqiang; Wang, Mingyang; Zhuang, Haowen; Chen, Jiangna; Lu, Lu; Wang, Lingjun*; Wang, Ting*广州中医药大学; 1
PHYTOMEDICINE2023-10DOI: 10.1016/j.phymed.2023.154955
1被引14閱讀
引用收藏
分享

摘要

Background: The Chinese herbal compound Xinmaikang (XMK) is effective in treating atherosclerosis (AS), although the associated mechanisms of action remain unclear. We hypothesize that XMK increases mitophagy via the PINK1/Parkin signaling pathway and decreases reactive oxygen species (ROS), thus treating AS. @@@ Purpose: To explore the above-mentioned mechanisms of action of XMK in AS. @@@ Materials and methods: Ultra-performance liquid chromatography assay was performed to clarify the composition of XMK. A 16-week high-fat diet was fed to APOE(-/-) mice to form an AS model. Next, mice were given XMK(0.95 g/kg/d, 1.99 g/kg/d, 3.98 g/kg/d, i.g.) or Atorvastatin(3 mg/kg/d, i.g.) or Rapamycin(4 mg/kg/d, i.p.) or XMK with Mdivi-1(40 mg/kg/d, i.p.) or an equivalent amount of normal saline for 4 weeks. Then mice were examined for AS plaque area, lesion area, collagen fiber, pro-inflammatory cytokines, lipid level, ROS level and mitophagy level. We assessed AS using Oil Red O, hematoxylin and eosin, and Sirius red staining, as well as ROS measurements. Mitophagy was evaluated by transmission electron microscopy, real-time quantitative polymerase chain reaction (RT-qPCR), Western blot, single-cell Western blot, and immunofluorescence staining. In vitro, by oxidizing low-density lipoprotein, formation of RAW264.7 macrophage-derived foam cells induced. we induced foam cell formation in RAW264.7 macrophages. Then cells were incubated with XMK-medicated serum with or without Mdivi-1. We examined foam cell formation, ROS level, mitophagy level in cells. Finally, we knocked down the PINK1, and examined foam cell formation and PINK1/Parkin level in RAW264.7 macrophages. @@@ Results: UPLC analysis revealed 102 main ingredients in XMK. In vivo, XMK at medium-dose or high-dose significantly reduced AS plaques, lipids, pro-inflammatory cytokines, and ROS and increased mitophagy. In further study, Single-cell western blot showed that mitophagy level in macrophages sorted from AS mice was lower than the control mice. While XMK improved mitophagy level. In vitro, XMK reduced foam cell formation and ROS and increased mitophagy. When PINK1 was knocked down, XMK's effects on foam cell formation and PINK1/Parkin pathway activation were reduced. @@@ Conclusion: The study shows that XMK is effective against AS by mediating macrophage mitophagy via the PINK1/Parkin signaling pathway. For the treatment of AS and drug discovery, it provides an experimental basis and target.

學科與關鍵詞

關鍵詞
AtherosclerosisMitophagyPINK1/ParkinMacrophageReactive oxygen specie
相關
載入中…

文獻載入失敗,請重試

重試

發表資訊

論文狀態
公開發表
期刊
PHYTOMEDICINE
發表日期
2023-10
卷期
第 119 卷
頁碼
154955
DOI
10.1016/j.phymed.2023.154955
語言
GERMAN
成果收錄
SCIE
資助標註
National Natural Science Foundation of China [81973776, 81973777, 2020A1515110132]; Guang-Dong Basic and Applied Basic Research Foundation; [81673920]

作者

  • C

    Cao, Yanhong (第一作者)

    guangzhou univ chinese med · 1

  • C

    Chen, Xin

    1 · guangzhou univ chinese med

查看全部 9 位作者收起作者
  • P

    Pan, Fuqiang

  • W

    Wang, Mingyang

    1 · guangzhou univ chinese med

  • Z

    Zhuang, Haowen

    1 · guangzhou univ chinese med

  • C

    Chen, Jiangna

  • L

    Lu, Lu

    1 · guangzhou univ chinese med

  • W

    Wang, Lingjun (通訊)

    1 · guangzhou univ chinese med

  • W

    Wang, Ting (通訊)

    guangzhou univ chinese med

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417